Autologous Hematopoietic Cell Transplantation for Core-binding Factor (CBF) Acute Myeloid Leukemia (AML) in the First Complete Remission (CR1)

NCT01146977 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

43

Enrollment

NETWORK

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

OTHER: HDAC chemotherapy
OTHER: Autologous HCT

Sponsor

Cooperative Study Group A for Hematology